PARSIPPANY, N.J., Nov. 5, 2015 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced it will report financial results for its 2015 third quarter ended September 30, 2015, on Thursday, November 12, 2015, after the close of the U.S. financial markets.
Management will host a conference call beginning at 4:30 p.m. Eastern Time on November 12, 2015, to discuss the results and to answer questions.
| Access information: |
|
| Date: |
Thursday, November 12, 2015 |
| Time: |
4:30 pm Eastern time |
| Dial-in numbers: |
877-407-8037 (Domestic) or 201-689-8037 (International) |
| Live web cast: |
www.pdi-inc.com, under "Investor Relations" |
The teleconference replay will be available two hours after completion through November 19, 2015 at 877-660-6853 (U.S. and Canada) or 201-612-7415. The replay passcode is 13623822. The archived web cast will be available for one year on the company's web site, www.pdi-inc.com, under "Investor Relations."
About PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States through its Commercial Services business, and developing and commercializing molecular diagnostic tests through its Interpace Diagnostics business. PDI's Commercial Services is focused on providing outsourced pharmaceutical, biotechnology, medical device and diagnostic sales teams to its corporate customers. PDI's Interpace Diagnostics is focused on developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for better patient diagnosis and management. For more information about us, please visit www.pdi-inc.com.
Logo - http://photos.prnewswire.com/prnh/20140114/NY45872LOGO
SOURCE PDI, Inc.
Share this article